May 27, 2025 - May 29, 2025
Status
listed
Issue Price
₹95.00 - ₹105.00
Lot Size
142 Shares
Subscription
96.68 times
Listing Price
Face Value
₹10 Per share
Issue Size
Approx ₹168 Cr
Fresh Issue
Approx ₹168 Cr
Total Shares Offered
-
Retail Quota
-
QIB Quota
-
HNI Quota
-
Retail Approx
-
S-HNI Approx
-
B-HNI Approx
-
Issue Type
Bookbuilding IPO
Listing On
BSE, NSE
Registrar
Kfin Technologies Limited
Pre issue Share Holding
100.00%
Post issue Share Holding
72.82%
Company Promoters
Choice Capital Advisors Pvt Ltd
Date | QIB | NII | NII (> ₹10L) | NII (< ₹10L) | Retail | Total |
---|---|---|---|---|---|---|
May 27, 2025 | 0.05 | 6.86 | 6.75 | 7.09 | 4.25 | 3.61 |
May 28, 2025 | 1.03 | 27.29 | 25.98 | 29.91 | 13.20 | 12.74 |
May 29, 2025 | 102.67 | 222.13 | 249.80 | 166.78 | 39.48 | 96.68 |
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 142 | ₹14,910 |
Retail (Max) | 13 | 1846 | ₹1,93,830 |
S-HNI (Min) | 14 | 1,988 | ₹2,08,740 |
S-HNI (Max) | 67 | 9,514 | ₹9,98,970 |
B-HNI (Min) | 68 | 9,656 | ₹10,13,880 |
KPI | Values |
---|---|
ROE | 31.41% |
ROCE | 32.41% |
Debt/Equity | 0.51 |
RoNW | 32.09% |
PAT Margin | 8.85 |
Price to Book Value | 5.34 |
Investor Category | Shares Offered | Maximum Allottees |
---|---|---|
Anchor Investor Shares Offered | - | NA |
QIB Shares Offered | 32,00,000 (28.57%) | NA |
NII (HNI) Shares Offered | 24,00,000 (21.43%) | - |
bNII > ₹10L | 16,00,000 (14.29%) | 804 |
sNII < ₹10L | 8,00,000 (7.14%) | 402 |
Retail Shares Offered | 56,00,000 (50.00%) | 39,436 |
Total Shares Offered | 1,12,00,000 (100%) | - |
Period Ended | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
---|---|---|---|---|
Assets | 230.04 | 203.05 | 155.39 | 98.03 |
Revenue | 270.27 | 259.23 | 232.35 | 172.05 |
Profit After Tax | 22.11 | 22.80 | 19.35 | 10.87 |
Net Worth | 107.24 | 84.30 | 61.00 | 40.95 |
Reserves and Surplus | 64.37 | 41.42 | 18.13 | 31.87 |
Total Borrowing | 60.37 | 43.47 | 24.85 | 3.21 |
plot no. el 79electronic zone, ttc, midc,mahape navi mumbai, thane
Phone: 022 4528 0500
Email: cs@prostarm.com
Website: https://prostarm.com/
Phone: 04067162222, 04079611000
Email: pisl.ipo@kfintech.com